Frederick R Appelbaum

Frederick R Appelbaum

UNVERIFIED PROFILE

Are you Frederick R Appelbaum?   Register this Author

Register author
Frederick R Appelbaum

Frederick R Appelbaum

Publications by authors named "Frederick R Appelbaum"

Are you Frederick R Appelbaum?   Register this Author

100Publications

3354Reads

46Profile Views

Maintenance therapy after allogeneic hematopoietic cell transplantation for acute myeloid leukemia.

Best Pract Res Clin Haematol 2019 Dec 18;32(4):101109. Epub 2019 Oct 18.

Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2019.101109DOI Listing
December 2019

Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources.

Biol Blood Marrow Transplant 2019 05 28;25(5):1045-1052. Epub 2018 Nov 28.

Clinical Research Division, Fred Hutchinson Cancer Research Center; Seattle, Washington; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine; Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.11.030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511303PMC
May 2019

Hematopoietic cell transplantation as treatment of patients with acute myeloid leukemia with measurable residual disease after consolidation therapy.

Best Pract Res Clin Haematol 2018 12 20;31(4):405-409. Epub 2018 Sep 20.

Fred Hutchinson Cancer Research Center and University of Washington, 100 Fairview Avenue N, D5-310, Seattle, WA 98109, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2018.09.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347460PMC
December 2018

Next-generation sequencing for measuring minimal residual disease in AML.

Nat Rev Clin Oncol 2018 08;15(8):473-474

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41571-018-0040-0
Publisher Site
http://dx.doi.org/10.1038/s41571-018-0040-0DOI Listing
August 2018

Impact of allogeneic hematopoietic cell transplantation on the outcome of older patients with acute myeloid leukemia.

Best Pract Res Clin Haematol 2017 12 22;30(4):320-326. Epub 2017 Sep 22.

Medical Oncology Division, University of Washington School of Medicine, and Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2017.09.004DOI Listing
December 2017

Flow cytometric demonstration of decrease in bone marrow leukemic blasts after 'Day 14' without further therapy in acute myeloid leukemia.

Leuk Lymphoma 2017 11 28;58(11):2717-2719. Epub 2017 Mar 28.

c Clinical Research Division , Fred Hutchinson Cancer Research Center , Seattle , WA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1307359DOI Listing
November 2017

Gemtuzumab ozogamicin for acute myeloid leukemia.

Blood 2017 11 11;130(22):2373-2376. Epub 2017 Oct 11.

Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-09-797712DOI Listing
November 2017

Early mortality and overall survival of acute myeloid leukemia based on facility type.

Am J Hematol 2017 Aug 1;92(8):764-771. Epub 2017 Jun 1.

Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, Nebraska.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24767DOI Listing
August 2017

Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117.

J Clin Oncol 2017 Aug 9;35(24):2745-2753. Epub 2017 May 9.

Mikkael A. Sekeres and Aziz Nazha, Cleveland Clinic, Cleveland; Clara D. Bloomfield, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Megan Othus and Anna Moseley, SWOG Statistical Center; Min Fang and Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan F. List, H. Lee Moffitt Cancer Center, Tampa, FL; Olatoyosi Odenike, University of Chicago, Chicago; Mario R. Velasco, Heartland NCORP/Cancer Care Specialists of Central Illinois, Decatur, IL; Richard M. Stone, Dana Farber Cancer Institute; Eyal C. Attar, Massachusetts General Hospital, Boston, MA; Steven D. Gore, Yale University, New Haven, CT; Mark R. Litzow, Mayo Clinic, Rochester, MN; Rena Buckstein, Sunnybrook Health Sciences Centre, Toronto; Elina K. Cook, Alyssa H. Cull, and Michael J. Rauh, Queen's University, Kingston, Ontario, Canada; Diane Roulston, University of Michigan, Ann Arbor, MI; Yanming Zhang, Memorial Sloan-Kettering Cancer Center, New York, NY; Rakesh Gaur, Kansas City National Cancer Institute Community Oncology Research Program, Prairie Village, KS; Ehab Atallah, Medical College of Wisconsin, Milwaukee, WI; and Harry P. Erba, University of Alabama, Birmingham, AL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.2510DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562170PMC
August 2017

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.

N Engl J Med 2017 08 23;377(5):454-464. Epub 2017 Jun 23.

From the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston (R.M.S.); the Division of Biomedical Statistics and Informatics (S.J.M., K.L.) and the Alliance Statistics and Data Center (S.J.M., K.L., S.G.), Mayo Clinic, Rochester, MN; the Alliance Statistics and Data Center, Duke University, Durham, NC (B.L.S.); the Ohio State University Comprehensive Cancer Center, Columbus (S.G., C.D.B., T.W.P., G.M., R.B.K.); Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden (C.T., G.E.), Department of Internal Medicine III, University Hospital of Ulm, Ulm (K.D., R.F.S., H.D.), Hematology and Oncology, University of Leipzig, Leipzig (D.N.), Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover (J.K., A.G.), and Department of Medicine II, Hematology-Oncology, Goethe University Hospital Frankfurt, Frankfurt am Main (H.S.) - all in Germany; the Department of Biomedicine and Prevention, University Tor Vergata, Rome (F.L.-C., S.A.); the Department of Clinical Haematology, Alfred Hospital and Monash University, Melbourne, VIC, Australia (A.W.); Hospital de la Santa Creu i Sant Pau, Hematology Department, Autonomous University of Barcelona, Barcelona (J.S.), and Hospital Universitario la Fe, Hematology Department, Department of Medicine, University of Valencia, Valencia (M.A.S.) - both in Spain; the Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto (J.M.B.); Radboud Institute Molecular Studies, Radboud University Medical Center, Nijmegen, the Netherlands (T.W.); the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle (F.R.A.); the Division of Hematology-Oncology, Stanford Comprehensive Cancer Center, Stanford University, Stanford, CA (B.C.M.); the Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (M.S.T.); and the Department of Medicine, University of Chicago, Chicago (R.A.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1614359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754190PMC
August 2017

Measure for Measure: Measuring the Impact of Measuring Residual Disease in Acute Myeloid Leukemia.

J Oncol Pract 2017 08;13(8):481-483

Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.025346DOI Listing
August 2017

CHIPs and engraftment dips.

Blood 2017 07;130(1):7-9

FRED HUTCHINSON CANCER RESEARCH CENTER.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-05-782664DOI Listing
July 2017

Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients.

Biol Blood Marrow Transplant 2017 Apr 3;23(4):691-696. Epub 2017 Jan 3.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.12.639DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465962PMC
April 2017

Consolidation chemotherapy prior to hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission.

Best Pract Res Clin Haematol 2016 12 19;29(4):365-371. Epub 2016 Oct 19.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Division of Medical Oncology, University of Washington School of Medicine, 1100 Fairview Avenue North, D5-310, PO Box 19024, Seattle, WA 98109-1024, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2016.10.012DOI Listing
December 2016

Cord-Blood Transplantation in Patients with Minimal Residual Disease.

N Engl J Med 2016 12;375(22):2204-2205

Fred Hutchinson Cancer Research Center, Seattle, WA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1612872DOI Listing
December 2016

Practice Patterns and Preferences Among Hematopoietic Cell Transplantation Clinicians.

Biol Blood Marrow Transplant 2016 11 29;22(11):2092-2099. Epub 2016 Jul 29.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067220PMC
http://dx.doi.org/10.1016/j.bbmt.2016.07.014DOI Listing
November 2016

Hematopoietic cell transplantation for adults with acute myeloid leukemia with minimal residual disease.

Best Pract Res Clin Haematol 2015 Jun-Sep;28(2-3):133-40. Epub 2015 Oct 22.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Division of Medical Oncology, University of Washington School of Medicine, 1100 Fairview Avenue North, D5-310, P.O. Box 19024, Seattle, WA 98109-1024, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2015.10.010DOI Listing
September 2016

Cord-Blood Transplantation in Patients with Minimal Residual Disease.

N Engl J Med 2016 Sep;375(10):944-53

From the Clinical Research Division, Fred Hutchinson Cancer Research Center (F.M., T.G., A.W., M.E.F., K.D., R.W., M.M., J.H.D., M.S., A.D., B.M.S., R.S., E.P., F.R.A., C.D.), and the Departments of Medicine (F.M., B.W., M.E.F., M.M., J.H.D., M.S., B.M.S., R.S., E.P., F.R.A.) and Pediatrics (A.W., A.D., C.D.), University of Washington - both in Seattle.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1602074DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513721PMC
September 2016

Maintenance therapy in acute myeloid leukemia: an evidence-based review of randomized trials.

Blood 2016 08 27;128(6):763-73. Epub 2016 Jun 27.

Section of Bone Marrow Transplantation and Leukemia Program, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-03-674127DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982451PMC
August 2016

Infusion of a non-HLA-matched ex-vivo expanded cord blood progenitor cell product after intensive acute myeloid leukaemia chemotherapy: a phase 1 trial.

Lancet Haematol 2016 Jul 7;3(7):e330-9. Epub 2016 Jun 7.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medical Oncology, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(16)30023-0DOI Listing
July 2016

Association between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patients.

Leuk Res 2016 Mar 15;42:68-74. Epub 2016 Jan 15.

Oncology Research Institute, Loyola University Health Sciences Division, Maywood, IL 60153, United States; Division of Hematology & Oncology, Department of Medicine, Loyola University Medical Center, Maywood, IL 60153, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2016.01.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779662PMC
March 2016

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?

J Clin Oncol 2016 Feb 14;34(4):329-36. Epub 2015 Dec 14.

Daisuke Araki, Brent L. Wood, Jerald P. Radich, Anna B. Halpern, Yi Zhou, Marco Mielcarek, Elihu H. Estey, Frederick R. Appelbaum, and Roland B. Walter, University of Washington; and Megan Othus, Jerald P. Radich, Marco Mielcarek, Elihu H. Estey, Frederick R. Appelbaum, and Roland B. Walter, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.3826DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872033PMC
February 2016

Comparative analysis of flow cytometry and morphology for the detection of acute myeloid leukaemia cells in cerebrospinal fluid.

Br J Haematol 2016 Jan 26;172(1):134-6. Epub 2015 May 26.

Clinical Research Division, Fred Hutchinson Cancer Research Centre, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13465DOI Listing
January 2016

Indications for allogeneic hematopoietic cell transplantation for acute myeloid leukemia in the genomic era.

Am Soc Clin Oncol Educ Book 2014 :e327-33

From the Fred Hutchinson Cancer Research Center, Division of Medical Oncology, Department of Medicine, University of Washington, Seattle Cancer Care Alliance.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2014.34.e327DOI Listing
December 2015

Hematopoietic Cell Transplantation after Solid Organ Transplantation.

Biol Blood Marrow Transplant 2015 Dec 10;21(12):2123-2128. Epub 2015 Aug 10.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington Medical Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.08.004DOI Listing
December 2015

Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG.

Haematologica 2015 Oct 9;100(10):e409-11. Epub 2015 Jul 9.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.130013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591777PMC
October 2015

Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia.

Cancer 2015 Sep 29;121(17):2900-8. Epub 2015 May 29.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29475DOI Listing
September 2015

Alternative donor transplantation for adults with acute leukemia.

Best Pract Res Clin Haematol 2014 Sep-Dec;27(3-4):272-7. Epub 2014 Oct 15.

Clinical Research Division, Fred Hutchinson Cancer Research Center, USA; Division of Medical Oncology, University of Washington School of Medicine, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2014.10.009DOI Listing
July 2015

Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia.

Haematologica 2015 Jul 20;100(7):e254-6. Epub 2015 Mar 20.

Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.118570DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486235PMC
July 2015

Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation.

Biol Blood Marrow Transplant 2015 May 31;21(5):848-54. Epub 2015 Jan 31.

Division of Clinical Research, Fred Hutchinson Cancer Research Center; Department of Medicine, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.01.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408250PMC
May 2015

Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report.

J Clin Oncol 2015 Apr 23;33(10):1157-64. Epub 2015 Feb 23.

Fabiana Ostronoff, Megan Othus, Elihu Estey, Frederick R. Appelbaum, Kenneth J. Kopecky, Min Fang, Vivian G. Oehler, Era L. Pogosova-Agadjanyan, Jerald P. Radich, Soheil Meshinchi, and Derek L. Stirewalt, Fred Hutchinson Cancer Research Center; Fabiana Ostronoff, Elihu Estey, Frederick R. Appelbaum, Min Fang, Vivian G. Oehler, Jerald P. Radich, and Derek L. Stirewalt, University of Washington; Stephen H. Petersdorf, Seattle Genetics, Seattle, WA; Michelle Lazenby, Anna Evans, Amanda Gilkes, and Alan Burnett, Cardiff University School of Medicine, Cardiff, United Kingdom; John Godwin, Providence Cancer Center Group and Earle A. Chiles Research Institute, Portland, OR; Alan F. List, H. Lee Moffitt Cancer Center, Tampa, FL; and Cheryl L. Willman, University of New Mexico, Albuquerque, NM.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/10/1157.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.58.0571
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.58.0571DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372852PMC
April 2015

Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia.

J Clin Oncol 2015 Apr 2;33(11):1258-64. Epub 2015 Mar 2.

Xueyan Chen, Brent L. Wood, Roland B. Walter, Pamela S. Becker, Janis L. Abkowitz, and Elihu H. Estey, University of Washington; and Hu Xie, Roland B. Walter, John M. Pagel, Pamela S. Becker, Vicky K. Sandhu, Frederick R. Appelbaum, and Elihu H. Estey, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.3518DOI Listing
April 2015

Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission.

Biol Blood Marrow Transplant 2015 Feb 30;21(2):373-8. Epub 2014 Sep 30.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.09.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297535PMC
February 2015

Reprint of: Allogeneic hematopoietic cell transplantation for acute myeloid leukemia.

Biol Blood Marrow Transplant 2015 Feb;21(2 Suppl):S3-10

Queen Elizabeth Hospital, Birmingham, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.12.032DOI Listing
February 2015

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia.

Biol Blood Marrow Transplant 2015 Jan 13;21(1):8-15. Epub 2014 Nov 13.

Queen Elizabeth Hospital, Birmingham, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.10.026DOI Listing
January 2015

SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia.

Br J Haematol 2014 Oct 18;167(2):233-7. Epub 2014 Jul 18.

Department of Hematologic Oncology and Blood Disorders, The Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188732PMC
October 2014

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation.

J Clin Oncol 2014 Oct 25;32(29):3249-56. Epub 2014 Aug 25.

Mohamed L. Sorror, Rainer F. Storb, Brenda M. Sandmaier, Fabiana Ostronoff, H. Joachim Deeg, Karen L. Syrjala, Elihu Estey, David G. Maloney, Frederick R. Appelbaum, Paul J. Martin, and Barry E. Storer, Fred Hutchinson Cancer Research Center; Mohamed L. Sorror, Rainer F. Storb, Brenda M. Sandmaier, Fabiana Ostronoff, H. Joachim Deeg, Karen L. Syrjala, Elihu Estey, David G. Maloney, Frederick R. Appelbaum, and Paul J. Martin, University of Washington School of Medicine; Barry E. Storer, University of Washington School of Public Health, Seattle, WA; Smita Bhatia, City of Hope School of Medicine, Duarte, CA; Richard T. Maziarz, Center for Hematologic Malignancies, Oregon Health & Science University Knight Cancer Institute and School of Medicine, Portland, OR; Michael A. Pulsipher, University of Utah School of Medicine and Primary Children's Medical Center, Huntsman Cancer Institute, Salt Lake City, UT; and Michael B. Maris, Colorado Blood Cancer Institute School of Medicine, Denver, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.8157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178523PMC
October 2014

Responsibility for costs associated with clinical trials.

J Clin Oncol 2014 Oct 15;32(30):3357-9. Epub 2014 Sep 15.

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine, Chicago, IL.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2014.57.1422
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.57.1422DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876354PMC
October 2014

Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.

Blood 2014 Jul 5;124(2):287-95. Epub 2014 May 5.

Clinical Statistics Program, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and Department of Biostatistics, University of Washington School of Public Health, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-01-550566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093684PMC
July 2014

Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphoma.

Biol Blood Marrow Transplant 2014 Jun 12;20(6):770-5. Epub 2014 Feb 12.

Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.02.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019701PMC
June 2014

Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia.

Leuk Res Treatment 2014 23;2014:421723. Epub 2014 Mar 23.

Division of Clinical Research, Fred Hutchinson Cancer Research Center, P.O. Box 19024, Seattle, WA 98109, USA ; Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/421723DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981457PMC
April 2014

Unsuccessful diagnostic cytogenetic analysis is a poor prognostic feature in acute myeloid leukaemia.

Br J Haematol 2014 Jan 28;164(2):245-50. Epub 2013 Oct 28.

Stanford University School of Medicine, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12625DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117470PMC
January 2014

Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission.

J Clin Oncol 2013 Nov 23;31(31):3883-8. Epub 2013 Sep 23.

Raya Mawad, Ted A. Gooley, Vicky Sandhu, Bart Scott, Brenda M. Sandmaier, Paul O'Donnell, Pamela S. Becker, Stephen Petersdorf, Kathleen Shannon Dorcy, Paul Hendrie, Mohamed L. Sorror, Roland B. Walter, H. Joachim Deeg, Frederick R. Appelbaum, Elihu H. Estey, and John M. Pagel, Fred Hutchinson Cancer Research Center; Raya Mawad, Bart Scott, Brenda M. Sandmaier, Paul O'Donnell, Pamela S. Becker, Stephen Petersdorf, Paul Hendrie, Mohamed L. Sorror, Roland B. Walter, H. Joachim Deeg, Frederick R. Appelbaum, Elihu H. Estey, and John M. Pagel, University of Washington, Seattle, WA; and Jack Lionberger, St Louis University, St Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.50.2567DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805928PMC
November 2013

Risk assessment before allogeneic hematopoietic cell transplantation for older adults with acute myeloid leukemia.

Expert Rev Hematol 2013 Oct 2;6(5):547-62. Epub 2013 Oct 2.

Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2013.827418DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875225PMC
October 2013

Acute myeloid leukemia, version 2.2013.

J Natl Compr Canc Netw 2013 Sep;11(9):1047-55

From 1City of Hope Comprehensive Cancer Center; 2Memorial Sloan-Kettering Cancer Center; 3Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 4Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 5Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 6Stanford Cancer Institute; 7Massachusetts General Hospital Cancer Center; 8University of Alabama at Birmingham Comprehensive Cancer Center; 9UCSF Helen Diller Family Comprehensive Cancer Center; 10Moffitt Cancer Center; 11UNMC Eppley Cancer Center at The Nebraska Medical Center; 12The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 13St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 14Fox Chase Cancer Center; 15Duke Cancer Institute; 16The University of Texas MD Anderson Cancer Center; 17Huntsman Cancer Institute at the University of Utah; 18The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 19Dana-Farber Cancer Institute; 20Vanderbilt-Ingram Cancer Center; 21Roswell Park Cancer Institute; and 22National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161234PMC
http://dx.doi.org/10.6004/jnccn.2013.0127DOI Listing
September 2013

Measurement of minimal residual disease before and after myeloablative hematopoietic cell transplantation for acute leukemia.

Best Pract Res Clin Haematol 2013 Sep 16;26(3):279-84. Epub 2013 Oct 16.

Clinical Research Division, Fred Hutchinson Cancer Research Center, USA; Division of Medical Oncology, University of Washington, School of Medicine, 1100 Fairview Avenue North, D5-310, PO Box 19024, Seattle, WA 98109-1024, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2013.10.008DOI Listing
September 2013

Implementing a Death with Dignity program at a comprehensive cancer center.

N Engl J Med 2013 Apr;368(15):1417-24

Fred Hutchinson Cancer Research Center, and the University of Washington, Seattle, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMsa1213398DOI Listing
April 2013